Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Passage Bio, Inc. (PASG)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
7.50-0.27 (-3.47%)
At close: 04:00PM EST
7.50 0.00 (0.00%)
After hours: 04:00PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close7.77
Open7.33
Bid6.70 x 800
Ask7.65 x 900
Day's Range7.33 - 7.65
52 Week Range6.80 - 30.87
Volume276,707
Avg. Volume395,649
Market Cap404.831M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateMay 05, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est29.43
  • Newsfile

    Moore Kuehn, PLLC Encourages Investors of Passage Bio, Inc. to Contact Law Firm

    New York, New York--(Newsfile Corp. - November 30, 2021) - Moore Kuehn, PLLC, a securities law firm located on Wall Street , is investigating whether certain officers and directors of Passage Bio, Inc. (NASDAQ: PASG) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms.If you own PASG please contact Justin Kuehn, Esq. by email at jkuehn@moorekuehn.com or telephone at (212) 709-

  • GlobeNewswire

    Passage Bio Announces Inducement Award Under Nasdaq Listing Rule 5635(c)(4)

    PHILADELPHIA, Nov. 19, 2021 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (Nasdaq: PASG), a clinical-stage genetic medicines company focused on developing transformative therapies for central nervous system (CNS) disorders, today announced it has granted an inducement award to a new employee. Passage Bio granted an option to purchase 130,000 shares of common stock to this employee as a material inducement to employment in accordance with Nasdaq Listing Rule 5635(c)(4). The stock option has an exercise p

  • Insider Monkey

    Top 10 Stock Picks of Jacob Doft’s Highline Capital Management

    In this article, we discuss the top 10 stock picks of Jacob Doft’s Highline Capital Management. If you want to skip our detailed analysis of these stocks, go directly to the Top 5 Stock Picks of Jacob Doft’s Highline Capital Management. Jacob Doft is the founder and chief executive officer at Highline Capital Management, which […]

Advertisement
Advertisement